Assessment of Lung Perfusion in Patients With Chronic Obstructive Pulmonary Disease Using FD MRI

Non-contrast-enhanced Perfusion Imaging of the Lung Using Fourier Decomposition Magnetic Resonance Imaging (FD MRI): Assessment of Feasibility in Patients With COPD in Correlation With Perfusion Scintigraphy, SPECT/CT and DCE MRI

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02367209

Acronym

FD-COPD

Enrollment

Registered

2015-02-20

Start date

2015-02-28

Completion date

2017-06-30

Last updated

2017-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

FD MRI, COPD, SPECT/CT, DCE MRI

Brief summary

Detailed description

In the recent years a novel method for functional lung imaging called Fourier decomposition MRI (FD MRI) has been introduced that allows for simultaneous assessment of regional lung perfusion and ventilation-related information without exposure to ionizing radiation or administration of intravenous or inhalational contrast agent. In this project, the investigators plan to investigate whether Fourier decomposition (FD) MRI is able to provide similar clinical information on regional lung perfusion as the standard methods SPECT/CT and DCE MRI in patients with COPD. As MRI in patients with COPD is particularly challenging due to the rarefication of lung parenchyma, the FD MRI technique will be combined with an ultra-fast Steady-State Free Precession (ufSSFP) acquisition method for improved signal efficiency. The investigators ultimate goal is to provide a mean to predict and monitor the outcome of different therapies, such as medication, valves and surgery in COPD patients without requiring ionizing radiation or administration of contrast agents. In the framework of this study, 30 patients with COPD will be enrolled prospectively. The study participants will be recruited by the clinic for thoracic surgery at the University Hospital Basel among all patients undergoing lung perfusion scintigraphy with SPECT/CT for surgery planning. Each participant will undergo one MRI examination of 30 min containing non-contrast-enhanced (FD MRI) and contrast-enhanced (DCE MRI) imaging studies of regional lung perfusion.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Informed Consent as documented by signature

Exclusion criteria

* Known hypersensitivity or allergy to Gd-based MRI contrast agents. * Patients with cardiac pacemakers, intra cranial clips, metallic foreign bodies\^or other not MRcompatible implants (e.g. pumps etc.). * Renal failure or severely impaired kidney function (eGFR \< 30 ml/min /1,73 m2) * Known or suspected non-compliance, claustrophobia. * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant. * Epilepsy. * Age \<18 years. * Previous enrolment into the current study. * Enrolment of the investigator, his/her family members, employees and other dependent persons.

Design outcomes

Primary

Measure	Time frame	Description
Relative perfusion	14 month	Relative perfusion of individual pulmonary lobes expressed in % of total (bilateral) lung perfusion

Secondary

Measure	Time frame	Description
Image quality	14 month	Subjective classification by two independent readers
Perfusion defects	14 month	Inter-reader agreement concerning the presence of circumscribed perfusion defects

Countries

Switzerland

Outcome results